Alteration in the ratio of PRA to PRB has been associated with breast cancer progression and this alteration often increased the ratio toward PRA [14], which may be caused by increased turnover of active, ligand-bound PRB [17]. This evidence concerns the gene RB1 and breast carcinoma.